Advertisement
Canada markets open in 7 hours 42 minutes
  • S&P/TSX

    21,947.41
    +124.21 (+0.57%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +449.98 (+1.18%)
     
  • CAD/USD

    0.7308
    -0.0000 (-0.01%)
     
  • CRUDE OIL

    78.47
    +0.36 (+0.46%)
     
  • Bitcoin CAD

    87,797.80
    +1,130.14 (+1.30%)
     
  • CMC Crypto 200

    1,336.01
    +59.03 (+4.62%)
     
  • GOLD FUTURES

    2,319.80
    +11.20 (+0.49%)
     
  • RUSSELL 2000

    2,035.72
    +19.61 (+0.97%)
     
  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     
  • NASDAQ futures

    17,994.75
    -6.00 (-0.03%)
     
  • VOLATILITY

    13.49
    -1.19 (-8.11%)
     
  • FTSE

    8,213.49
    +41.34 (+0.51%)
     
  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     
  • CAD/EUR

    0.6788
    +0.0001 (+0.01%)
     

Image Guided Surgery Devices Market to Reach $4.7 Billion by 2027

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 8. - Influencer Pool: 11681. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, April 01, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Image Guided Surgery Devices Industry" - https://www.reportlinker.com/p05960989/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.

Abstract:
- Global Image Guided Surgery Devices Market to Reach $4.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Image Guided Surgery Devices estimated at US$3.5 Billion in the year 2020, is projected to reach a revised size of US$4.7 Billion by 2027, growing at a CAGR of 4.3% over the analysis period 2020-2027. Computed Tomography Scanners, one of the segments analyzed in the report, is projected to record a 5.2% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Ultrasound Systems segment is readjusted to a revised 3.8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1 Billion, While China is Forecast to Grow at 4% CAGR
- The Image Guided Surgery Devices market in the U.S. is estimated at US$1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$832.4 Million by the year 2027 trailing a CAGR of 4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 3.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.
- Magnetic Resonance Imaging Segment to Record 4.7% CAGR
- In the global Magnetic Resonance Imaging segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$322.7 Million in the year 2020 will reach a projected size of US$445.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$539 Million by the year 2027.

- Select Competitors (Total 38 Featured) -

  • Analogic Corporation

  • BrainLab AG

  • GE Healthcare

  • Karl Storz GmbH & Co. KG

  • Koninklijke Philips NV

  • Medtronic PLC

  • Olympus Corporation

  • Siemens Healthineers

  • Stryker Corporation

  • Varian Medical Systems, Inc.

ADVERTISEMENT




Read the full report: https://www.reportlinker.com/p05960989/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Image Guided
Surgery Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Image Guided Surgery Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Image Guided Surgery
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Computed
Tomography Scanners by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Computed Tomography Scanners
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Computed Tomography
Scanners by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Ultrasound Systems
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Ultrasound Systems by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Ultrasound Systems by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Magnetic
Resonance Imaging by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Magnetic Resonance Imaging
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Magnetic Resonance
Imaging by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Endoscope by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Endoscope by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Endoscope by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 16: World Current & Future Analysis for X-ray Fluoroscopy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 17: World Historic Review for X-ray Fluoroscopy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for X-ray Fluoroscopy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Positron Emission
Tomography by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 20: World Historic Review for Positron Emission
Tomography by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 21: World 15-Year Perspective for Positron Emission
Tomography by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Single Photon
Emission Computed Tomography by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Single Photon Emission
Computed Tomography by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Single Photon Emission
Computed Tomography by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Cardiac Surgery
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 26: World Historic Review for Cardiac Surgery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Cardiac Surgery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Neurosurgery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 29: World Historic Review for Neurosurgery by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Neurosurgery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Orthopedic
Surgery by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 32: World Historic Review for Orthopedic Surgery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Orthopedic Surgery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Urology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 35: World Historic Review for Urology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for Urology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 37: World Current & Future Analysis for Gastroenterology
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 38: World Historic Review for Gastroenterology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 39: World 15-Year Perspective for Gastroenterology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 40: World Current & Future Analysis for Oncology Surgery
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 41: World Historic Review for Oncology Surgery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 42: World 15-Year Perspective for Oncology Surgery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 43: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 44: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 45: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 46: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 47: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 48: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 49: World Current & Future Analysis for Ambulatory
Surgery Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 50: World Historic Review for Ambulatory Surgery Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 51: World 15-Year Perspective for Ambulatory Surgery
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 52: World Current & Future Analysis for Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 53: World Historic Review for Clinics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 54: World 15-Year Perspective for Clinics by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 55: World Current & Future Analysis for Research &
Academic Institutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 56: World Historic Review for Research & Academic
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 57: World 15-Year Perspective for Research & Academic
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 58: USA Current & Future Analysis for Image Guided
Surgery Devices by Device Type - Computed Tomography Scanners,
Ultrasound Systems, Magnetic Resonance Imaging, Endoscope,
X-ray Fluoroscopy, Positron Emission Tomography and Single
Photon Emission Computed Tomography - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 59: USA Historic Review for Image Guided Surgery Devices
by Device Type - Computed Tomography Scanners, Ultrasound
Systems, Magnetic Resonance Imaging, Endoscope, X-ray
Fluoroscopy, Positron Emission Tomography and Single Photon
Emission Computed Tomography Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 60: USA 15-Year Perspective for Image Guided Surgery
Devices by Device Type - Percentage Breakdown of Value Sales
for Computed Tomography Scanners, Ultrasound Systems, Magnetic
Resonance Imaging, Endoscope, X-ray Fluoroscopy, Positron
Emission Tomography and Single Photon Emission Computed
Tomography for the Years 2012, 2020 & 2027

Table 61: USA Current & Future Analysis for Image Guided
Surgery Devices by Application - Cardiac Surgery, Neurosurgery,
Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 62: USA Historic Review for Image Guided Surgery Devices
by Application - Cardiac Surgery, Neurosurgery, Orthopedic
Surgery, Urology, Gastroenterology, Oncology Surgery and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 63: USA 15-Year Perspective for Image Guided Surgery
Devices by Application - Percentage Breakdown of Value Sales
for Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology,
Gastroenterology, Oncology Surgery and Other Applications for
the Years 2012, 2020 & 2027

Table 64: USA Current & Future Analysis for Image Guided
Surgery Devices by End-Use - Hospitals, Ambulatory Surgery
Centers, Clinics and Research & Academic Institutes -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 65: USA Historic Review for Image Guided Surgery Devices
by End-Use - Hospitals, Ambulatory Surgery Centers, Clinics and
Research & Academic Institutes Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 66: USA 15-Year Perspective for Image Guided Surgery
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Ambulatory Surgery Centers, Clinics and Research &
Academic Institutes for the Years 2012, 2020 & 2027

CANADA
Table 67: Canada Current & Future Analysis for Image Guided
Surgery Devices by Device Type - Computed Tomography Scanners,
Ultrasound Systems, Magnetic Resonance Imaging, Endoscope,
X-ray Fluoroscopy, Positron Emission Tomography and Single
Photon Emission Computed Tomography - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 68: Canada Historic Review for Image Guided Surgery
Devices by Device Type - Computed Tomography Scanners,
Ultrasound Systems, Magnetic Resonance Imaging, Endoscope,
X-ray Fluoroscopy, Positron Emission Tomography and Single
Photon Emission Computed Tomography Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 69: Canada 15-Year Perspective for Image Guided Surgery
Devices by Device Type - Percentage Breakdown of Value Sales
for Computed Tomography Scanners, Ultrasound Systems, Magnetic
Resonance Imaging, Endoscope, X-ray Fluoroscopy, Positron
Emission Tomography and Single Photon Emission Computed
Tomography for the Years 2012, 2020 & 2027

Table 70: Canada Current & Future Analysis for Image Guided
Surgery Devices by Application - Cardiac Surgery, Neurosurgery,
Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 71: Canada Historic Review for Image Guided Surgery
Devices by Application - Cardiac Surgery, Neurosurgery,
Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 72: Canada 15-Year Perspective for Image Guided Surgery
Devices by Application - Percentage Breakdown of Value Sales
for Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology,
Gastroenterology, Oncology Surgery and Other Applications for
the Years 2012, 2020 & 2027

Table 73: Canada Current & Future Analysis for Image Guided
Surgery Devices by End-Use - Hospitals, Ambulatory Surgery
Centers, Clinics and Research & Academic Institutes -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 74: Canada Historic Review for Image Guided Surgery
Devices by End-Use - Hospitals, Ambulatory Surgery Centers,
Clinics and Research & Academic Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 75: Canada 15-Year Perspective for Image Guided Surgery
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Ambulatory Surgery Centers, Clinics and Research &
Academic Institutes for the Years 2012, 2020 & 2027

JAPAN
Table 76: Japan Current & Future Analysis for Image Guided
Surgery Devices by Device Type - Computed Tomography Scanners,
Ultrasound Systems, Magnetic Resonance Imaging, Endoscope,
X-ray Fluoroscopy, Positron Emission Tomography and Single
Photon Emission Computed Tomography - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 77: Japan Historic Review for Image Guided Surgery
Devices by Device Type - Computed Tomography Scanners,
Ultrasound Systems, Magnetic Resonance Imaging, Endoscope,
X-ray Fluoroscopy, Positron Emission Tomography and Single
Photon Emission Computed Tomography Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 78: Japan 15-Year Perspective for Image Guided Surgery
Devices by Device Type - Percentage Breakdown of Value Sales
for Computed Tomography Scanners, Ultrasound Systems, Magnetic
Resonance Imaging, Endoscope, X-ray Fluoroscopy, Positron
Emission Tomography and Single Photon Emission Computed
Tomography for the Years 2012, 2020 & 2027

Table 79: Japan Current & Future Analysis for Image Guided
Surgery Devices by Application - Cardiac Surgery, Neurosurgery,
Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 80: Japan Historic Review for Image Guided Surgery
Devices by Application - Cardiac Surgery, Neurosurgery,
Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 81: Japan 15-Year Perspective for Image Guided Surgery
Devices by Application - Percentage Breakdown of Value Sales
for Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology,
Gastroenterology, Oncology Surgery and Other Applications for
the Years 2012, 2020 & 2027

Table 82: Japan Current & Future Analysis for Image Guided
Surgery Devices by End-Use - Hospitals, Ambulatory Surgery
Centers, Clinics and Research & Academic Institutes -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 83: Japan Historic Review for Image Guided Surgery
Devices by End-Use - Hospitals, Ambulatory Surgery Centers,
Clinics and Research & Academic Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 84: Japan 15-Year Perspective for Image Guided Surgery
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Ambulatory Surgery Centers, Clinics and Research &
Academic Institutes for the Years 2012, 2020 & 2027

CHINA
Table 85: China Current & Future Analysis for Image Guided
Surgery Devices by Device Type - Computed Tomography Scanners,
Ultrasound Systems, Magnetic Resonance Imaging, Endoscope,
X-ray Fluoroscopy, Positron Emission Tomography and Single
Photon Emission Computed Tomography - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 86: China Historic Review for Image Guided Surgery
Devices by Device Type - Computed Tomography Scanners,
Ultrasound Systems, Magnetic Resonance Imaging, Endoscope,
X-ray Fluoroscopy, Positron Emission Tomography and Single
Photon Emission Computed Tomography Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 87: China 15-Year Perspective for Image Guided Surgery
Devices by Device Type - Percentage Breakdown of Value Sales
for Computed Tomography Scanners, Ultrasound Systems, Magnetic
Resonance Imaging, Endoscope, X-ray Fluoroscopy, Positron
Emission Tomography and Single Photon Emission Computed
Tomography for the Years 2012, 2020 & 2027

Table 88: China Current & Future Analysis for Image Guided
Surgery Devices by Application - Cardiac Surgery, Neurosurgery,
Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 89: China Historic Review for Image Guided Surgery
Devices by Application - Cardiac Surgery, Neurosurgery,
Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 90: China 15-Year Perspective for Image Guided Surgery
Devices by Application - Percentage Breakdown of Value Sales
for Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology,
Gastroenterology, Oncology Surgery and Other Applications for
the Years 2012, 2020 & 2027

Table 91: China Current & Future Analysis for Image Guided
Surgery Devices by End-Use - Hospitals, Ambulatory Surgery
Centers, Clinics and Research & Academic Institutes -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 92: China Historic Review for Image Guided Surgery
Devices by End-Use - Hospitals, Ambulatory Surgery Centers,
Clinics and Research & Academic Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 93: China 15-Year Perspective for Image Guided Surgery
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Ambulatory Surgery Centers, Clinics and Research &
Academic Institutes for the Years 2012, 2020 & 2027

EUROPE
Table 94: Europe Current & Future Analysis for Image Guided
Surgery Devices by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 95: Europe Historic Review for Image Guided Surgery
Devices by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 96: Europe 15-Year Perspective for Image Guided Surgery
Devices by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027

Table 97: Europe Current & Future Analysis for Image Guided
Surgery Devices by Device Type - Computed Tomography Scanners,
Ultrasound Systems, Magnetic Resonance Imaging, Endoscope,
X-ray Fluoroscopy, Positron Emission Tomography and Single
Photon Emission Computed Tomography - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 98: Europe Historic Review for Image Guided Surgery
Devices by Device Type - Computed Tomography Scanners,
Ultrasound Systems, Magnetic Resonance Imaging, Endoscope,
X-ray Fluoroscopy, Positron Emission Tomography and Single
Photon Emission Computed Tomography Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 99: Europe 15-Year Perspective for Image Guided Surgery
Devices by Device Type - Percentage Breakdown of Value Sales
for Computed Tomography Scanners, Ultrasound Systems, Magnetic
Resonance Imaging, Endoscope, X-ray Fluoroscopy, Positron
Emission Tomography and Single Photon Emission Computed
Tomography for the Years 2012, 2020 & 2027

Table 100: Europe Current & Future Analysis for Image Guided
Surgery Devices by Application - Cardiac Surgery, Neurosurgery,
Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 101: Europe Historic Review for Image Guided Surgery
Devices by Application - Cardiac Surgery, Neurosurgery,
Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 102: Europe 15-Year Perspective for Image Guided Surgery
Devices by Application - Percentage Breakdown of Value Sales
for Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology,
Gastroenterology, Oncology Surgery and Other Applications for
the Years 2012, 2020 & 2027

Table 103: Europe Current & Future Analysis for Image Guided
Surgery Devices by End-Use - Hospitals, Ambulatory Surgery
Centers, Clinics and Research & Academic Institutes -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 104: Europe Historic Review for Image Guided Surgery
Devices by End-Use - Hospitals, Ambulatory Surgery Centers,
Clinics and Research & Academic Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 105: Europe 15-Year Perspective for Image Guided Surgery
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Ambulatory Surgery Centers, Clinics and Research &
Academic Institutes for the Years 2012, 2020 & 2027

FRANCE
Table 106: France Current & Future Analysis for Image Guided
Surgery Devices by Device Type - Computed Tomography Scanners,
Ultrasound Systems, Magnetic Resonance Imaging, Endoscope,
X-ray Fluoroscopy, Positron Emission Tomography and Single
Photon Emission Computed Tomography - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 107: France Historic Review for Image Guided Surgery
Devices by Device Type - Computed Tomography Scanners,
Ultrasound Systems, Magnetic Resonance Imaging, Endoscope,
X-ray Fluoroscopy, Positron Emission Tomography and Single
Photon Emission Computed Tomography Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 108: France 15-Year Perspective for Image Guided Surgery
Devices by Device Type - Percentage Breakdown of Value Sales
for Computed Tomography Scanners, Ultrasound Systems, Magnetic
Resonance Imaging, Endoscope, X-ray Fluoroscopy, Positron
Emission Tomography and Single Photon Emission Computed
Tomography for the Years 2012, 2020 & 2027

Table 109: France Current & Future Analysis for Image Guided
Surgery Devices by Application - Cardiac Surgery, Neurosurgery,
Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery
and Other Applications - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 110: France Historic Review for Image Guided Surgery
Devices by Application - Cardiac Surgery, Neurosurgery,
Orthopedic Surgery, Urology, Gastroenterology, Oncology Surgery
and Other Applications Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 111: France 15-Year Perspective for Image Guided Surgery
Devices by Application - Percentage Breakdown of Value Sales
for Cardiac Surgery, Neurosurgery, Orthopedic Surgery, Urology,
Gastroenterology, Oncology Surgery and Other Applications for
the Years 2012, 2020 & 2027

Table 112: France Current & Future Analysis for Image Guided
Surgery Devices by End-Use - Hospitals, Ambulatory Surgery
Centers, Clinics and Research & Academic Institutes -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 113: France Historic Review for Image Guided Surgery
Devices by End-Use - Hospitals, Ambulatory Surgery Centers,
Clinics and Research & Academic Institutes Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 114: France 15-Year Perspective for Image Guided Surgery
Devices by End-Use - Percentage Breakdown of Value Sales for
Hospitals, Ambulatory Surgery Centers, Clinics and Research &
Academic Institutes for the Years 2012, 2020 & 2027

GERMANY
Table 115: Germany Current & Future Analysis for Image Guided
Surgery Devices by Device Type - Computed Tomography Scanners,
Ultrasound Systems, Magnetic Resonance Imaging, Endoscope,
X-ray Fluoroscopy, Positron Emission Tomography and Single
Photon Emission Computed Tomography - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05960989/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001